Search results
BAP Pharma opens US HQ in Somerset
NJBIZ· 17 hours agoThe event featured company leaders, officials and other dignitaries, according to a May 1 announcement. BAP Pharma, which was established in 2011, is a...
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in...
FOX21 Colorado Springs· 3 days ago(Nasdaq: ALNY), the leading RNAi therapeutics company, announced today a further expansion...
After years of caution, pharma advertisers are embracing influencer marketing
Digiday· 6 hours ago“I’ve always found pharma, as an industry, to be a couple steps behind,” said Klick Health executive...
Allucent Recognized with CRO Leadership Awards for Expertise and Compatibility
The Fairfax County Times· 17 hours agoAllucent, a global mid-sized clinical research organization (CRO), received two CRO Leadership Awards presented by Clinical Leader and...customers' expectations. This year ...
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Reuters via Yahoo Finance· 3 days agoWith this deal, Ono Pharma joins Japanese rivals Takeda Pharmaceutical and Astellas Pharma which have spent big recently to replenish their drug pipelines ...
Allspring Global Investments Holdings LLC Buys 1,191 Shares of UroGen Pharma Ltd. (NASDAQ:URGN)
ETF DAILY NEWS· 3 days agoAllspring Global Investments Holdings LLC lifted its stake in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 31.6% in the 4th quarter, according to the ...
Geodis obtains IATA CEIV Pharma certification for its Copenhagen hub - The Loadstar
The Loadstar· 4 days agoGEODIS now has a total of 28 CEIV Pharma certified sites across its global network in the Americas,...
Q1 2024 IQVIA Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 hours agoA top 5 pharma bought IQVIA's Omnichannel Navigator solution to assess return on marketing investment, measure customer interactions and campaign performance and make data-driven ...
Poolbeg Pharma confirms US patent grant
Proactive Investors· 2 days agoPoolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has been granted a full patent in the United States for its drug candidate POLB 001, aimed at treating and...
Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint
WRBL Columbus· 2 days agoJacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary ...
